This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Hoffmann-La Roche Inc., Evotech International Gmbh, Recursion Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2026
Title: The Innovative Contributions of Andrew Simon Bell
Introduction
Andrew Simon Bell is a notable inventor based in Dundee, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 3 patents, Bell's work focuses on developing new compounds that have potential therapeutic applications.
Latest Patents
Among his latest patents, Bell has developed sulfone derivatives, which provide compounds of formula I. Additionally, he has created pyrazolopyrimidine compounds that act as adenosine receptor antagonists. These inventions include a compound of formula (I), or pharmaceutically acceptable esters, amides, carbamates, solvates, or salts thereof, including a salt of such an ester, amide, or carbamate.
Career Highlights
Throughout his career, Andrew Simon Bell has worked with several prominent companies in the pharmaceutical industry. Notably, he has been associated with Recursion Pharmaceuticals, Inc. and Evotech International GmbH. His work in these organizations has allowed him to further his research and development efforts in innovative drug discovery.
Collaborations
Bell has collaborated with talented individuals in his field, including Luke Green and Jérémy Besnard. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Andrew Simon Bell's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to influence the development of new therapeutic compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile